Celltrion’s Vegzelma Becomes Fourth US-Approved Bevacizumab

Estimated US Market Launch Date Is H1 2023

Label that reads "FDA APPROVED" on top a portion of the American Flag
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products